Abstract
BackgroundPatients with rheumatoid arthritis (RA) with moderate to high disease activity are primarily treated with disease-modifying anti-rheumatic drugs (DMARDs). Since the late 1990s, patients who do not achieve remission despite...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
